The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists

Diabetic kidney disease (DKD) remains the main cause for chronic kidney disease (CKD) and end-stage kidney disease (ESKD) worldwide. Both CKD and ESKD lead to major increases in risk of cardiovascular disease and death in people with diabetes. Despite optimal management of lifestyle, glucose levels...

Descripción completa

Detalles Bibliográficos
Autores principales: van Baar, Michaël J. B., van der Aart, Annemarie B., Hoogenberg, Klaas, Joles, Jaap A., Heerspink, Hiddo J. L., van Raalte, Daniël H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657126/
https://www.ncbi.nlm.nih.gov/pubmed/31384419
http://dx.doi.org/10.1177/2042018819865398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657126/
https://www.ncbi.nlm.nih.gov/pubmed/31384419
http://dx.doi.org/10.1177/2042018819865398

Ejemplares similares